HYD 0.00% 1.1¢ hydrix limited

Ann: Appendix 4C - quarterly, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,519 Posts.
    lightbulb Created with Sketch. 6981
    Market Update
    KEY POINTS • Transformation of Panorama Synergy (“PSY”) continues with the integration of Hydrix • Hydrix and Memphasys (ASX: MEM) announce collaboration to build next generation equipment to assist the global IVF market • Hydrix continues to win new multi-stage product development work for a variety of clients • PSY continues to advance commercial discussions with a number of Agricultural partners
    MARKET UPDATE  
    The transformation of PSY continues with the integration of the Hydrix operation. Hydrix group is an innovative specialist design and engineering services business developing sophisticated products for customers worldwide.
    Leveraging the R&D strengths of  PSY with Hydrix’s large group of development engineers has resulted in the acceleration of commercial projects as set out below:
    • Memphasys (ASX: MEM) has signed an agreement with Hydrix to develop ‘Felix’ its lead product designed to prepare sperm for use in artificial insemination. MEM is a developer of cutting-edge proprietary technology to combat male infertility. Alison Coutts the Executive Chairman of MEM said that, “Memphasys is excited to work with Hydrix to develop our insemination device. Hydrix has an unparalled track record in developing medical technology and the success of Felix will help many childless couples to be able to conceive’. Stage 1 of the project, to develop a prototype for clinical validation, is estimated at $600,000. The entire project has an estimated value of $1.6M over the next 18-24 months. • In line with earlier customer announcements, Hydrix has secured orders for follow on stages of development work for Queensland Brain Institute’s novel Alzheimer’s treatment device, and Bivacor’s unique artificial heart and control device.
    PSY continues to advance commercial conversations with a number of agricultural clients towards the development of custom spectrometry devices using the Company’s proprietary MEMS sensor technology.
    Panorama Synergy (ASX: PSY) is a technology company focused on the commercialisation of its  microelectromechanical systems (MEMS) sensor technology.  Combining the engineering capability and experience of Hydrix, the Company provides valuable capability and exposure to the growing multi-billiondollar MEMS spectroscopy, sensors and Internet of Things (IoT) markets
    – ENDS Contact Information: Panorama Synergy Limited E: [email protected]
 
watchlist Created with Sketch. Add HYD (ASX) to my watchlist
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $2.796M
Open High Low Value Volume
1.1¢ 1.1¢ 1.1¢ $527 48.36K

Buyers (Bids)

No. Vol. Price($)
5 700099 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 613427 3
View Market Depth
Last trade - 14.29pm 11/11/2024 (20 minute delay) ?
HYD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.